WCN25-1553 EFFICACY AND SAFETY OF DAILY ORAL STEROID AND CYCLOPHOSPHAMIDE VERSUS CYCLICAL STEROID AND CYCLOPHOSPHAMIDE IN ADULT PATIENTS WITH MEMBRANOUS NEPHROPATHY :A RANDOMIZED CONTROLLED TRIAL
Membranous nephropathy(MN)is the most common cause of nephrotic syndrome in the elderly. The most widely accepted treatment is alternate monthly steroid and cyclophosphamide, also known as the modified Ponti celli regimen(MPR). It requires hospitalization for three days every alternate month for six months. Considering the widely different educational and economical background of patients at our centre, compliance to MPR may not be universal. We want to compare a complete oral regimen of steroid and cyclophosphamide for 6 months with MPR.
Authors
- Sandip Kumar Panda (ORCID: https://orcid.org/0000-0003-4487-8600)
- Suvendu Purkait (ORCID: https://orcid.org/0000-0003-4501-5540)
- Priti Meena (ORCID: https://orcid.org/0000-0001-6073-8101)
- Anish Garg
- Paromita Das (ORCID: https://orcid.org/0000-0003-0322-3835)
Institutions
- All India Institute of Medical Sciences Bhubaneswar (IN)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.381
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00